DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/rmls76/investigation) has appear the accession of the “Investigation Address on China Rivaroxaban Market, 2010-2019” address to their offering.
According to some experts, rivaroxaban and dabigatran are the best able antithrombotic agents which will add a new anniversary to the development of cardiovascular drugs. Rivaroxaban is the aboriginal accessible orally alive absolute agency Xa inhibitor developed by Bayer/ Johnson & Johnson. In Oct. 2008, rivaroxaban was accustomed to appear into the Canada and the EU bazaar beneath the barter name of Xarelto while on Jul. 1, 2011, it was accustomed by FDA to access the American market. Rivaroxaban has been accustomed by added than 100 countries in the apple and succeeded in entering over 75 countries. According to the statistics of Bayer/ Johnson & Johnson, the sales amount of rivaroxaban in the apple exceeded USD 2.124 billion in 2013, accretion by 219% compared with aftermost year.
After rivaroxaban entering the Chinese bazaar beneath the barter name of Xarelto in the closing bisected of 2009, it develops fast with anniversary sales ascent from beneath than CNY 20 actor in 2010 to CNY 140 actor in 2014 and CAGR extensive up to over 70% during the aeon of 2010-2014. Currently, the rivaroxaban bazaar in China has been absorbed by Bayer. The amount of rivaroxaban is almost aerial for it is imported. The amount ambit of 10 mg rivaroxaban (tablets, 5 tab. per package) is 364.20-388.68 CNY/package in sample hospitals with cities differing hardly in its price. Some Chinese enterprises accept been developing the all-encompassing drugs of rivaroxaban. And it is estimated that the bazaar admeasurement of rivaroxaban in China will accumulate accretion in the aing few years.
Key Topics Covered:
1 Related Concepts of Rivaroxaban
2 Bazaar Profile of Rivaroxaban in China
3 Survey on Sales Status of Rivaroxaban in China, 2010-2014
4 Survey on Bazaar Share of Major Manufacturers of Rivaroxaban in China, 2010-2014
5 Survey on Dosage Forms of Rivaroxaban in China, 2010-2014
6 Reference Amount of Rivaroxaban in Chinese Hospitals in 2014
7 Major Manufacturers of Rivaroxaban in Chinese Market, 2010-2014
8 Bazaar Outlook of Rivaroxaban in China, 2015-2019
– Bayer AG (Germany)
– Bayer HealthCare
For added advice appointment http://www.researchandmarkets.com/research/rmls76/investigation
Seven Things About Xarelto Dosage Forms You Have To Experience It Yourself | Xarelto Dosage Forms – xarelto dosage forms
| Allowed to my personal website, within this period I’ll show you regarding xarelto dosage forms